skip to Main Content
Aug 01 2018

Comparison of carvedilol and metoprolol on clinical outcomes in patients with CHF (COMET)

Clinical Question: What is the effect of carvedilol vs metoprolol tartrate on mortality and morbidity in patients with heart failure with reduced ejection fraction (HFrEF) and NYHA class II-IV symptoms?

Take Away: In patients with HFrEF, carvedilol reduces all-cause mortality compared to metoprolol tartrate.

 

 

Back To Top
Login
Log in below to access learning modules.
Forgot Password
Enter your email address or username and we’ll send you instructions to reset your password.